The addition of molecular biology to the existing range of imaging technologies is creating opportunities for scientists of many disciplines. Paul Smaglik lines up the pieces. Convergence is the watchword for a multitude of trends in biomedical imaging: imaging joined with therapy, for example, or positron emission tomography (PET) used with magnetic resonance imaging (MRI). It's also about applying methods traditionally used in hospitals to basic research, and tweaking them to improve drug development.
展开▼
